Pharma companies overcharged consumers by ₹10,000 crore despite price controls: data

Pharmaceutical companies have allegedly overcharged consumers by more than ₹10,000 crore despite price caps imposed on essential medicines, according to data from the National Pharmaceutical Pricing Authority (NPPA).

The regulator has raised recovery demands under Drug Price Control Orders for charging prices higher than approved limits.

As of September 2025, NPPA has raised total demands of ₹10,013.3 crore, of which ₹8,526.1 crore remains unrecovered.

A significant portion of the pending amount—around ₹5,938.7 crore—is currently under litigation or dispute, with companies challenging NPPA’s recovery orders in courts.

Recovery has remained slow, with only ₹1,487.1 crore collected so far. NPPA data also shows that recovery in the first six months of 2025–26 increased compared to the previous year, though legal challenges continue to delay enforcement against several major pharmaceutical firms.

Recoveries raised (including interest) during FY 2025–26

Swiss Garnier Genexiaa Sciences Pvt Ltd – Nifutin 100 mg tablets: ₹12.81 crore

Torrent Pharmaceuticals – Regestrone CR 10 tablets: ₹6.58 crore

USV Ltd – Clopidogrel 75 mg tablets: ₹4.54 crore

Unichem Laboratories Ltd – Trilostar 6.25 tablets: ₹3.32 crore

Lupin Ltd – Telista 20 tablets: ₹2.37 crore

(Recoveries made up to September 2025 include ₹3.03 crore from Torrent Pharmaceuticals, ₹1.86 crore from USV Ltd, ₹1.35 crore from Unichem Laboratories Ltd, and ₹87.86 lakh from Lupin Ltd)

Related Posts

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

During the raid, the accused were allegedly found storing medicines and pharmaceutical drugs without valid licences, permits or authorisations and replacing labels on the stored medicines. The Directorate of Enforcement…

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Hyderabad startup PopVax develops personalised cancer vaccines using AI, machine learning, and mRNA tech to target unique tumour mutations. Cancer treatment is increasingly moving towards personalised approaches that take into…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Medicines that cure Us are making Our Environment Sick

Medicines that cure Us are making Our Environment Sick

ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

PGIMS recalls drug amid probe into deaths

PGIMS recalls drug amid probe into deaths

NPPA list brings little relief: No price cut for 25% cancer drugs

NPPA list brings little relief: No price cut for 25% cancer drugs